Amundi
WST icon

Amundi’s West Pharmaceutical WST Stock Holding History

Amundi’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138M Sell
385,311
-258,754
-40% -$79.1M 0.03% 391
2026
Q1 		$161M Buy
644,065
+296,639
+85% +$73.8M 0.04% 327
2025
Q4 		$95.6M Buy
347,426
+62,976
+22% +$17.2M 0.03% 498
2025
Q3 		$76.3M Sell
284,450
-218,381
-43% -$53.1M 0.02% 465
2025
Q2 		$111M Buy
502,831
+228,696
+83% +$48.9M 0.04% 392
2025
Q1 		$60.3M Sell
274,135
-57,646
-17% -$15.9M 0.02% 510
2024
Q4 		$112M Buy
331,781
+93,692
+39% +$29.5M 0.04% 403
2024
Q3 		$68.2M Sell
238,089
-126,351
-35% -$38.7M 0.03% 484
2024
Q2 		$117M Buy
364,440
+36,189
+11% +$12.8M 0.04% 343
2024
Q1 		$124M Sell
328,251
-50,764
-13% -$18.8M 0.05% 336
2023
Q4 		$132M Buy
379,015
+214
+0.1% +$75.7K 0.06% 328
2023
Q3 		$146M Buy
378,801
+825
+0.2% +$319K 0.07% 284
2023
Q2 		$143M Buy
377,976
+28,026
+8% +$10M 0.07% 295
2023
Q1 		$121M Buy
349,950
+51,518
+17% +$15.1M 0.07% 309
2022
Q4 		$75M Sell
298,432
-116,954
-28% -$27.7M 0.04% 411
2022
Q3 		$108M Buy
415,386
+138,698
+50% +$42.3M 0.06% 315
2022
Q2 		$81.5M Buy
276,688
+9,315
+3% +$3.03M 0.07% 302
2022
Q1 		$112M Sell
267,373
-5,940
-2% -$2.33M 0.08% 275
2021
Q4 		$104M Sell
273,313
-31,876
-10% -$13.7M 0.07% 313
2021
Q3 		$130M Buy
305,189
+4,198
+1% +$1.77M 0.09% 240
2021
Q2 		$108M Buy
+300,991
New +$99.4M 0.08% 274

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Amundi's WST Position: Q2 2026 in Review

Amundi reduced its West Pharmaceutical (WST) stake by 40% in Q2 2026, selling an estimated $79.1M and leaving 385,311 shares worth $138M. The position accounts for 0.03% of the portfolio, ranked #391.

Amundi first reported a position in WST in Q2 2021 and has held it in 21 quarters since. The position peaked at $161M in Q1 2026. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Amundi held 385,311 shares of West Pharmaceutical worth $138M as of Q2 2026.
  • Amundi sold 258,754 West Pharmaceutical shares in Q2 2026, an estimated $79.1M.
  • West Pharmaceutical made up 0.03% of Amundi's portfolio in Q2 2026, its #391 holding.
  • Amundi first reported a position in West Pharmaceutical in Q2 2021 and has held it in 21 quarters since.
  • Amundi's West Pharmaceutical position peaked at $161M in Q1 2026.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.